AstraZeneca Job Cuts: 600 US Sales Roles Go in $1.5B Savings Drive
AstraZeneca is cutting about 600 US respiratory and immunology sales jobs, Bloomberg reports, the first visible step in its $1.5 billion-a-year savings plan.
AstraZeneca is cutting about 600 US respiratory and immunology sales jobs, Bloomberg reports, the first visible step in its $1.5 billion-a-year savings plan.